| Veronica Lynn Bieniek, | |
|
201 N Forest Ct, Addison, IL 60101-2918 | |
| (630) 965-4208 | |
| Not Available |
| Full Name | Veronica Lynn Bieniek |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 201 N Forest Ct, Addison, Illinois |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205695681 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 146.017605 (Illinois) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Veronica Lynn Bieniek, 110 E Schubert Ave, Glendale Heights, IL 60139-2077 Ph: (630) 689-7568 | Veronica Lynn Bieniek, 201 N Forest Ct, Addison, IL 60101-2918 Ph: (630) 965-4208 |
News Archive
Westside Medical Associates of Los Angeles and Westside Medical Imaging (WMI) of Beverly Hills announce the benefit of early positron emission tomography (PET) scanning to identify Alzheimer's in its early more treatable phase.
Bloomberg: "The U.S. House Judiciary Committee voted to repeal the insurance industry's federal antitrust exemption in a move aimed at spurring competition and controlling the cost of premiums. The panel, in a 20-9 vote, approved legislation to ban companies from engaging in price fixing, bid rigging and market allocation.
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced new data from two pivotal Phase III efficacy trials for suvorexant, the investigational medicine Merck is developing for the treatment of insomnia. In the studies, suvorexant significantly reduced the time it took patients to fall asleep and increased the time that patients stayed asleep as early as the first night and at the three-month time point compared to placebo. The investigational medicine met statistical significance for all primary endpoints except for one measurement at Month 3 in one of the trials. These late-breaking data were presented here today at SLEEP 2012, the 26th Annual Meeting of the Associated Professional Sleep Societies.
UK-based researchers have developed a blood test that can predict whether patients with breast cancer will experience a relapse after receiving treatment, months before tumors are visible using hospital scans.
› Verified 9 days ago
Miss Kyla Nikol Bunch, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2171 W Executive Dr, Addison, IL 60101 Phone: 630-766-0505 | |
Erin Kristine Dini, SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 2171 W Executive Dr Ste 500, Addison, IL 60101 Phone: 630-766-0505 Fax: 630-766-6465 | |
Mrs. Amanda Guida, M.A. CCC-SLP/L Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 720 N Lincoln Ave, Addison, IL 60101 Phone: 630-458-3060 | |
Anita Marie Costabile, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1215 W Fullerton Ave, Addison, IL 60101 Phone: 630-372-2565 | |
Elin N Kuzmack, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2171 W Executive Dr Ste 500, Addison, IL 60101 Phone: 630-766-0505 | |
Sandra Lee Petersen, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 805 W Stonemill Ave, Addison, IL 60101 Phone: 630-628-4165 |